EX-10.2
Senti Biosciences Holdings, Inc.
EQUITY COMMITMENT LETTER
CPIF II-9 Limited
PO Box 500, Suite 210, 2nd Floor, Windward III, Regatta Office Park
Grand Cayman, Cayman Islands, KY1-1106
September 3, 2026
To: Senti Biosciences Holdings, Inc.
2 Corporate Drive, First Floor
South San Francisco, CA 94080
Ladies and Gentlemen:
This letter agreement sets forth the commitment of CPIF II-9 Limited (“Investor”) to Senti Biosciences Holdings, Inc. (“Company”) in connection with the Agreement and Plan of Merger dated July 14, 2026 (the “Merger Agreement”) among the Company, Investor, Senti Merger Sub, Inc. (“Merger Sub”), Senti Holdings, Inc. (“Midco”) and Senti Biosciences, Inc. (“Opco”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to them in the Merger Agreement.
…